MHMulin He

Mulin He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mulin He has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Xian-Cheng Jiang

    Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, USA

    5 shared publications
  • Tilla S. Worgall

    Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA

    3 shared publications
  • Zhiqiang Li

    Department of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA

    3 shared publications
  • Alexander Lee-Papastavros

    Section for Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA

    2 shared publications
  • Andy Ma

    Section for Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA

    2 shared publications
  • Guangzhi Chen

    Department of Cell Biology, State University of New York, Downstate Health Sciences University, Brooklyn (Z.L., M.H., G.C., T.S., X.-C.J.).

    2 shared publications

Latest Publications

  • Loss of function of ALDH3B2 transdifferentiates human pancreatic duct cells into β-like cells

    by Jian Li, Kevin Bode, Yu-Chi Lee, Noelle Morrow, Andy Ma, Mulin He, Siying Wei, Jessica da Silva Pereira, Taylor Stewart, Alexander Lee-Papastavros, et al.

    Replenishment of pancreatic β cells is key to a cure for diabetes. β cell regeneration is achieved predominantly by self-replication, especially in rodents, but it was also shown that pancreatic duct cells can transdifferentiate into β cells. How pancreatic duct cells are transdifferentiated and whether we can manipulate transdifferentiation to replenish β cell mass are not well understood. Using a genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screen, we found that the loss of function of aldehyde dehydrogenase family 3 member B2 ( ALDH3B2 ) was sufficient to transdifferentiate cell line–based and human pancreatic duct cells into functional β-like cells. The transdifferentiated cells had substantially increased the expression of β cell marker genes, secreted insulin in response to glucose, and lowered blood glucose to near normal for 6 weeks after transplantation into streptozotocin-induced diabetic mice under the kidney capsule. Our study identifies a gene that could potentially be targeted in human pancreatic duct cells to replenish β cell mass for diabetes therapy.


  • Open Access

    Loss-of-function of ALDH3B2 transdifferentiates human pancreatic duct cells into beta-like cells

    by Peng Yi, Jian Li, Yu-Chi Lee, Noelle Morrow, Jennifer Hollister-Lock, Brooke Sullivan, Taylor Stewart, Siying Wei, Jessica Pereira, Alexander Lee-Papastavros, et al.

    Replenishment of pancreatic beta cells is a key to the cure for diabetes. Beta cells regeneration is achieved predominantly by self-replication especially in rodents, but it was also shown that pancreatic duct cells can transdifferentiate into beta cells. How pancreatic duct cells were transdifferentiated and whether we could manipulate the transdifferentiation to replenish beta cell mass is not well understood. Using a genome-wide CRISPR screen, we discovered that loss-of-function of ALDH3B2 is sufficient to transdifferentiate human pancreatic duct cells into functional beta-like cells. The transdifferentiated cells have significant increase in beta cell marker genes expression, secrete insulin in response to glucose, and reduce blood glucose when transplanted into diabetic mice. Our study identifies a novel gene that we could potentially target in human pancreatic duct cells to replenish beta cell mass for diabetes therapy.

  • Open Access

    Effect of phospholipid transfer protein on plasma sphingosine-1-phosphate

    by Quiana Jones, Jiao Zheng, Zhiqiang Li, Mulin He, Xiang Li, Kezhi Dai, Tilla S. Worgall, Yang Yu, Xian-Cheng Jiang


  • Open Access

    Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease

    by Yeun-Po Chiang, Zhiqiang Li, Mulin He, Quiana Jones, Meixia Pan, Xianlin Han, Xian-Cheng Jiang


  • Effect of Total SMS Activity on LDL Catabolism in Mice

    by Zhiqiang Li, Mulin He, Guangzhi Chen, Tade Souaiaia, Tilla S. Worgall, Xian-Cheng Jiang

    Background: Sphingomyelin (SM) and cholesterol are 2 key lipid partners on cell membranes and on lipoproteins. Many studies have indicated the influence of cholesterol on SM metabolism. This study examined the influence of SM biosynthesis on cholesterol metabolism. Methods: Inducible global Sms1 KO (knockout)/global Sms2 KO mice were prepared to evaluate the effect of whole-body SM biosynthesis deficiency on lipoprotein metabolism. Tissue cholesterol, SM, ceramide, and glucosylceramide levels were measured. Triglyceride production rate and LDL (low-density lipoprotein) catabolism were measured. Lipid rafts were isolated and LDL receptor mass and function were evaluated. Also, the effects of exogenous sphingolipids on hepatocytes were investigated. Results: We found that total SMS (SM synthase) depletion significantly reduced plasma SM levels. Also, the total deficiency significantly induced plasma cholesterol, apoB (apolipoprotein B), and apoE (apolipoprotein E) levels. Importantly, total SMS deficiency, but not SMS2 deficiency, dramatically decreased LDL receptors in the liver and attenuated LDL uptake through the receptor. Further, we found that total SMS deficiency greatly reduced LDL receptors in the lipid rafts, which contained significantly lower SM and significantly higher glucosylceramide, as well as cholesterol. Furthermore, we treated primary hepatocytes and Huh7 cells (a human hepatoma cell line) with SM, ceramide, or glucosylceramide, and we found that only SM could upregulate LDL receptor levels in a dose-dependent fashion. Conclusions: Whole-body SM biosynthesis plays an important role in LDL cholesterol catabolism. The total SMS deficiency, but not SMS2 deficiency, reduces LDL uptake and causes LDL cholesterol accumulation in the circulation. Given the fact that serum SM level is a risk factor for cardiovascular diseases, inhibiting SMS2 but not SMS1 should be the desirable approach.


  • Open Access

    Effect of Total Sphingomyelin Synthase Activity on Low Density Lipoprotein Catabolism in Mice

    by Zhiqiang Li, Mulin He, Guangzhi Chen, Tilla S. Worgall, Xian-Cheng Jiang

    Background: Sphingomyelin (SM) and cholesterol are two key lipid partners on cell membranes and on lipoproteins. Many studies have indicated the influence of cholesterol on SM metabolism. This study examined the influence of SM biosynthesis on cholesterol metabolism. Methods: Inducible global Sms1 KO/global Sms2 KO mice were prepared to evaluate the effect of whole-body SM biosynthesis deficiency on lipoprotein metabolism. Tissue cholesterol, SM, ceramide, and glucosylceramide levels were measured. TG production rate and LDL catabolism were measured. Lipid rafts were isolated and LDL receptor mass and function were evaluated. Also, the effects of exogenous sphingolipids on hepatocytes were investigated. Results: We found that total SMS depletion significantly reduced plasma SM levels. Also, the total deficiency significantly induced plasma cholesterol, apoB, and apoE levels. Importantly, total SMS deficiency, but not SMS2 deficiency, dramatically decreased LDL receptors in the liver and attenuated LDL uptake through the receptor. Further, we found that total SMS deficiency greatly reduced LDL receptors in the lipid rafts which contained significantly lower SM and significantly higher glucosylceramide as well as cholesterol. Furthermore, we treated primary hepatocytes and Huh7 cells (a human hepatoma cell line) with SM, ceramide, or glucosylceramide, and we found that only SM could up-regulate LDL receptor levels in a dose-dependent fashion. Conclusions: Whole-body SM biosynthesis plays an important role in LDL-cholesterol catabolism. The total SMS deficiency, but not SMS2 deficiency, reduces LDL uptake and causes LDL-cholesterol accumulation in the circulation. Given the fact that serum SM level is a risk factor for cardiovascular diseases, inhibiting SMS2 but not SMS1 should be the desirable approach. Graphic

  • Open Access

    Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism

    by Zhiqiang Li, Yeun-Po Chiang, Mulin He, Ke Zhang, Jiao Zheng, Weihua Wu, Jiajia Cai, Yong Chen, Guangzhi Chen, Yunqin Chen, et al.